Floatz logo

Dextromethorphan

Traumatic Brain Injury

Avanir PharmaceuticalsSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

83 Active assets in the Traumatic Brain Injury cohort.

Asset / SponsorPhaseRating
MELATONIN
Children's National Research Institute
Phase 4BBB
Valproic Acid
Northwestern University
Phase 4BBB
Apsolol
Tanta University
Phase 4BBB
NEPENTHE
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
Amantadine
SHINKEI Therapeutics, Inc
Phase 4BB

View all 50 →

Same molecule, other indications

Dextromethorphan is also rated in:

stroke disorderDormant
BBB
Indicative · Phase 4
73 / 100
View asset →
major depressive disorderActive
BB
Indicative · Phase 4
68 / 100
View asset →
treatment-refractory schizophreniaActive
BB
Indicative · Phase 4
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →